Picture of Lunit logo

328130 — Lunit News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Lunit Enters Into Research Collaboration To Explore The Use Of AI To Improve The Effectiveness Of Immunotherapy

Oct 27 (Reuters) - Lunit Inc  328130.KQ :
    * LUNIT ENTERS INTO RESEARCH COLLABORATION TO EXPLORE THE
USE OF
AI TO IMPROVE THE EFFECTIVENESS OF IMMUNOTHERAPY
    * LUNIT INC - LUNIT TO SUPPORT MD ANDERSON RESEARCHERS
STUDYING
IMMUNE PHENOTYPE BIOMARKERS FOR PEMBROLIZUMAB TREATMENT RESPONSE

Source text for Eikon:  ID:nPn8HR30Qa 
Further company coverage:  328130.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lunit

See all news